'Developing a new drug is stumbling in the dark without a map. We are building the GPS'

22 mai 2022 | Sagi Cohen
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
 Site référencé:  Haaretz

Haaretz 

CNN report suggests Al Jazeera journalist killed by deliberate Israeli gunfire
24/05/2022
Tales of torture in Israel affirms need for sweeping Shin Bet legislation
24/05/2022
Haaretz Cartoon
24/05/2022
Israeli settlers pepper-spray baby near West Bank outpost, says father
24/05/2022
Biden to keep Iran's Revolutionary Guards on terror list in 'final' decision, says report
24/05/2022
Netanyahu was pressured to approve deadly Meron celebrations, testifier says
24/05/2022